Paclitaxel is under clinical development by DAE HWA Pharmaceutical and currently in Phase I for Ovarian Cancer.

Stride Arcolab arm has got US FDA nod to market Paclitaxel Injection, reports CNBC-TV18. It touched an intraday high of Rs 364 and an intraday low of Rs 350. At 11:20 hrs the share was quoting at ...

This leaflet answers some common questions about ANZATAX Injection Concentrate (Paclitaxel). It does not contain all the available information. It does not take the place of talking to your doctor ...

How tissue fluidity affects brain tumor development Huiyu Pharmaceutical's Paclitaxel Injection to be incl ...

INR:6196. india vs nz u19 world cup scorecard New approach promotes CAR-T cell survival and proliferation in solid tumors ...